EU approves Danish plan to put EUR 108m behind Bavarian Nordic's Covid-19 vaccine

The Danish state's plan to award EUR 108m to support phase III studies of Bavarian Nordic's covid-19 vaccine has been approved by the EU Commission.
Photo: Philip Davali/Ekstra Bladet
Photo: Philip Davali/Ekstra Bladet
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT

The EU Commission, which works alongside competition authorities from member states, announced on Monday that it will allow the Danish state to offer Bavarian Nordic EUR 108m to support the development of its Covid-19 vaccine.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading